Sarika Manoj Ramachandran, MD - Medicare Dermatology in Branford, CT

Sarika Manoj Ramachandran, MD is a medicare enrolled "Dermatology" physician in Branford, Connecticut. She went to State University Of New York At Stony Brook, School Of Medicine and graduated in 2007 and has 17 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice Yale University and her current practice location is 5 S Main St Ste 511, Branford, Connecticut. You can reach out to her office (for appointments etc.) via phone at (203) 481-3419.

Sarika Manoj Ramachandran is licensed to practice in Connecticut (license number 054168) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1427218262.

Contact Information

Sarika Manoj Ramachandran, MD
5 S Main St Ste 511,
Branford, CT 06405-3846
(203) 481-3419
Not Available



Physician's Profile

Full NameSarika Manoj Ramachandran
GenderFemale
SpecialityDermatology
Experience17 Years
Location5 S Main St Ste 511, Branford, Connecticut
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Sarika Manoj Ramachandran attended and graduated from State University Of New York At Stony Brook, School Of Medicine in 2007
  NPI Data:
  • NPI Number: 1427218262
  • Provider Enumeration Date: 06/16/2008
  • Last Update Date: 06/24/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 0547431744
  • Enrollment ID: I20150730011641

Medical Identifiers

Medical identifiers for Sarika Manoj Ramachandran such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1427218262NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology 262111 (New York)Secondary
207N00000XDermatology 054168 (Connecticut)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Yale-new Haven HospitalNew haven, CTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Yale University94360617362241

News Archive

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

Masimo announced today that a new clinical study published in Anesthesia & Analgesia demonstrates that Masimo noninvasive and continuous methemoglobin (SpMet®) measurements provide a high degree of agreement in measurements with corresponding laboratory values of methemoglobin obtained by invasive methemoglobin testing. In addition, the authors concluded that SpMet could facilitate early diagnosis and treatment of methemoglobinemia during high-risk procedures.

Despite national guidelines, teen boys still get inadequate HIV/STI counseling

Despite national guidelines aimed at improving sexual health services for teenagers, most sexually active boys - even those who report high-risk sexual behaviors - still get too little counseling about HIV and other sexually transmitted infections (STIs) during their visits to the doctor, according to a study led by researchers at Johns Hopkins Children's Center.

Scientists design small molecules that recognize myotonic dystrophy-associated RNAs

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.

WellPoint to accept results of HITRUST CSF assessments

WellPoint, Inc., the nation's largest health insurer by medical membership, announced today it will accept the results of HITRUST Common Security Framework assessments as a way to evaluate and verify its business partners' capabilities for protecting health information.

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sarika Manoj Ramachandran allows following entities to bill medicare on her behalf.
Entity NameYale University
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205822236
PECOS PAC ID: 9436061736
Enrollment ID: O20031105000015

News Archive

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

Masimo announced today that a new clinical study published in Anesthesia & Analgesia demonstrates that Masimo noninvasive and continuous methemoglobin (SpMet®) measurements provide a high degree of agreement in measurements with corresponding laboratory values of methemoglobin obtained by invasive methemoglobin testing. In addition, the authors concluded that SpMet could facilitate early diagnosis and treatment of methemoglobinemia during high-risk procedures.

Despite national guidelines, teen boys still get inadequate HIV/STI counseling

Despite national guidelines aimed at improving sexual health services for teenagers, most sexually active boys - even those who report high-risk sexual behaviors - still get too little counseling about HIV and other sexually transmitted infections (STIs) during their visits to the doctor, according to a study led by researchers at Johns Hopkins Children's Center.

Scientists design small molecules that recognize myotonic dystrophy-associated RNAs

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.

WellPoint to accept results of HITRUST CSF assessments

WellPoint, Inc., the nation's largest health insurer by medical membership, announced today it will accept the results of HITRUST Common Security Framework assessments as a way to evaluate and verify its business partners' capabilities for protecting health information.

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

Read more Medical News

› Verified 5 days ago

Entity NameYale Dermatology Associates Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003991357
PECOS PAC ID: 9436145497
Enrollment ID: O20040423000874

News Archive

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

Masimo announced today that a new clinical study published in Anesthesia & Analgesia demonstrates that Masimo noninvasive and continuous methemoglobin (SpMet®) measurements provide a high degree of agreement in measurements with corresponding laboratory values of methemoglobin obtained by invasive methemoglobin testing. In addition, the authors concluded that SpMet could facilitate early diagnosis and treatment of methemoglobinemia during high-risk procedures.

Despite national guidelines, teen boys still get inadequate HIV/STI counseling

Despite national guidelines aimed at improving sexual health services for teenagers, most sexually active boys - even those who report high-risk sexual behaviors - still get too little counseling about HIV and other sexually transmitted infections (STIs) during their visits to the doctor, according to a study led by researchers at Johns Hopkins Children's Center.

Scientists design small molecules that recognize myotonic dystrophy-associated RNAs

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.

WellPoint to accept results of HITRUST CSF assessments

WellPoint, Inc., the nation's largest health insurer by medical membership, announced today it will accept the results of HITRUST Common Security Framework assessments as a way to evaluate and verify its business partners' capabilities for protecting health information.

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sarika Manoj Ramachandran is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sarika Manoj Ramachandran, MD
5 S Main St Ste 511,
Branford, CT 06405-3846

Ph: (203) 481-3419
Sarika Manoj Ramachandran, MD
5 S Main St Ste 511,
Branford, CT 06405-3846

Ph: (203) 481-3419

News Archive

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

Masimo announced today that a new clinical study published in Anesthesia & Analgesia demonstrates that Masimo noninvasive and continuous methemoglobin (SpMet®) measurements provide a high degree of agreement in measurements with corresponding laboratory values of methemoglobin obtained by invasive methemoglobin testing. In addition, the authors concluded that SpMet could facilitate early diagnosis and treatment of methemoglobinemia during high-risk procedures.

Despite national guidelines, teen boys still get inadequate HIV/STI counseling

Despite national guidelines aimed at improving sexual health services for teenagers, most sexually active boys - even those who report high-risk sexual behaviors - still get too little counseling about HIV and other sexually transmitted infections (STIs) during their visits to the doctor, according to a study led by researchers at Johns Hopkins Children's Center.

Scientists design small molecules that recognize myotonic dystrophy-associated RNAs

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.

WellPoint to accept results of HITRUST CSF assessments

WellPoint, Inc., the nation's largest health insurer by medical membership, announced today it will accept the results of HITRUST Common Security Framework assessments as a way to evaluate and verify its business partners' capabilities for protecting health information.

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

Read more News

› Verified 5 days ago


Dermatology Doctors in Branford, CT

Laura Madden, MD
Dermatology
Medicare: Medicare Enrolled
Practice Location: 6 Business Park Dr Ste 204, Branford, CT 06405
Phone: 203-208-4082    
Aisha Sethi, M.D
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 5 S Main St, Branford, CT 06405
Phone: 203-481-3419    Fax: 203-481-2830

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.